Literature DB >> 16715114

Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.

A Kuendgen, R Fenk, I Bruns, M Dommach, A Schutte, R Engers, A Hünerlitürkoglu, R Haas, G Kobbe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16715114     DOI： 10.1038/sj.bmt.1705382

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

Review 1.  Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Authors:  Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

Review 2.  Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis.

Authors:  M G Kim; N Han; E-K Lee; T Kim
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

Review 3.  Splenic rupture following lenograstim in post-autologous stem cell transplantation treated with emergency open splenectomy: a case report and literature review.

Authors:  Uros Markovic; Cristina Colarossi; Antonio Iuppa; Paola Scire; Ausilia Gorgone; Federica Galbo; Gabriella Amato; Gaetano Moschetti
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

Review 4.  Comparison of pegfilgrastim prescribing practice to national guidelines at a university hospital outpatient oncology clinic.

Authors:  Geralyn E Waters; Patricia Corrigan; Mandy Gatesman; Thomas J Smith
Journal:  J Oncol Pract       Date:  2012-11-06       Impact factor: 3.840

5.  Atraumatic idiopathic splenic rupture induced by granulocyte-colony stimulating factor (G-CSF) for the treatment of pancytopenia, managed successfully by laparoscopic splenectomy.

Authors:  Ugochukwu Chinyere Chinaka; Joshua Fultang; Jelizaveta Pereca; Abdulmajid Ali
Journal:  BMJ Case Rep       Date:  2020-04-09

6.  AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse.

Authors:  Clare Samuelson; Stefan Radtke; Margaret Cui; Anai Perez; Hans-Peter Kiem; Olivier Humbert
Journal:  Exp Hematol       Date:  2020-12-01       Impact factor: 3.084

7.  Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis.

Authors:  Paola Mancino; Katia Falasca; Claudio Ucciferri; Eligio Pizzigallo; Jacopo Vecchiet
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-03-31       Impact factor: 2.576

8.  Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation.

Authors:  Khalid Ahmed Al-Anazi
Journal:  Bone Marrow Res       Date:  2012-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.